A study of SB206 in the treatment of genital warts caused by human papillomavirus.
Phase of Trial: Phase III
Latest Information Update: 05 Dec 2016
At a glance
- Drugs Nitric oxide (Primary)
- Indications Genital warts
- Focus Therapeutic Use
- 05 Dec 2016 New trial record
- 29 Nov 2016 According to a Novan Inc media release, the company plans to initiate this study in the second half of 2017.